Literature DB >> 25354914

The role of MRI in the assessment of the local status of anal carcinomas and in their management.

É Jederán1, J Lővey, Z Szentirmai, E Hitre, G Léránt, K Horváth, M Gődény.   

Abstract

This study aims to define the role of Magnetic Resonance (MR) examinations in the assessment and therapy of anal cancer (AC), and to present the main features of the MR examinations and the typical tumor spread pattern. The MR examinations of 67 anal cancer patients with histologically confirmed planocellular cancer were analyzed retrospectively. The tumor size and the signal intensity, the nodal status were examined before and after the treatment, and in recidive tumors (N = 13). At the time of the diagnosis the primary tumor was in early stage (Tis, T1, T2) in 71.5 % of the cases, and it was localized in 97 %. In 97.4 % of the cases the tumor had relatively increased signal intensities compared to the adjacent muscles. Patients received chemo-radiotherapy (CRT). After CRT in 26 out of 39 patients (66.7 %) the size of the tumor decreased (in 75 %), and the signal intensity decreased on the T2 weighted (T2w) images. In the residual tumor cases (19/39) verified 6 patients out of 19 had further decrease in size, and signal intensity a year after the end of the therapy. The MR examination plays a key role in the therapy of AC, by assessing the precise local status, the possible recidive tumors, and monitoring the therapy.

Entities:  

Mesh:

Year:  2014        PMID: 25354914     DOI: 10.1007/s12253-014-9857-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  30 in total

1.  Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation.

Authors:  D M Koh; A Dzik-Jurasz; B O'Neill; D Tait; J E Husband; G Brown
Journal:  Br J Radiol       Date:  2008-02       Impact factor: 3.039

Review 2.  Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Authors:  R Glynne-Jones; J Northover; J Oliveira
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

Review 3.  Anal canal and perianal epidermoid cancers.

Authors:  P R Fuchshuber; M Rodriguez-Bigas; T Weber; N J Petrelli
Journal:  J Am Coll Surg       Date:  1997-11       Impact factor: 6.113

4.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

Authors: 
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

5.  Magnetic resonance imaging of anal cancer.

Authors:  S C Roach; P A Hulse; F J Moulding; R Wilson; B M Carrington
Journal:  Clin Radiol       Date:  2005-10       Impact factor: 2.350

6.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

Authors:  H Bartelink; F Roelofsen; F Eschwege; P Rougier; J F Bosset; D G Gonzalez; D Peiffert; M van Glabbeke; M Pierart
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

Review 7.  Cancer of the anal region.

Authors:  Lisa Licitra; Silvia Spinazzé; Roberto Doci; T R Jeffry Evans; Gunnar Tanum; Michel Ducreux
Journal:  Crit Rev Oncol Hematol       Date:  2002-07       Impact factor: 6.312

8.  Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.

Authors:  E Touboul; M Schlienger; L Buffat; D Lefkopoulos; F Pène; R Parc; E Tiret; D Gallot; M Malafosse; A Laugier
Journal:  Cancer       Date:  1994-03-15       Impact factor: 6.860

9.  Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging.

Authors:  S D Otto; L Lee; H J Buhr; B Frericks; S Höcht; A J Kroesen
Journal:  J Gastrointest Surg       Date:  2009-04-14       Impact factor: 3.452

10.  Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.

Authors:  Ramin Roohipour; Sujata Patil; Karyn A Goodman; Bruce D Minsky; W Douglas Wong; José G Guillem; Philip B Paty; Martin R Weiser; Heather B Neuman; Jinru Shia; Deborah Schrag; Larissa K F Temple
Journal:  Dis Colon Rectum       Date:  2008-01-08       Impact factor: 4.585

View more
  2 in total

Review 1.  Cancer of the Anal Canal: Diagnosis, Staging and Follow-Up with MRI.

Authors:  Carole Durot; Anthony Dohan; Mourad Boudiaf; Vincent Servois; Philippe Soyer; Christine Hoeffel
Journal:  Korean J Radiol       Date:  2017-09-21       Impact factor: 3.500

2.  Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy.

Authors:  Pratik Adusumilli; Noha Elsayed; Stelios Theophanous; Robert Samuel; Rachel Cooper; Nathalie Casanova; Damien J Tolan; Alexandra Gilbert; Andrew F Scarsbrook
Journal:  Eur Radiol       Date:  2022-03-11       Impact factor: 7.034

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.